3.0.0 2113 2023-01-11T13:35:58Z 2023-01-11T13:35:58Z House HR 2017-04-20 115 [Congressional Record Volume 163, Number 68 (Thursday, April 20, 2017)]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. STIVERS:H.R. 2113.Congress has the power to enact this legislation pursuantto the following:This bill is enacted pursuant to the power granted toCongress under Article I, section 8, Clause 3 of the UnitedStates Constitution. The Constitution's Commerce Clauseallows Congress to enact laws when reasonably related to theregulation of interstate commerce.[Page H2812]]]> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2017-04-21T15:08:52Z Referred to 2017-04-20T20:01:20Z 2017-04-21 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2017-04-20 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2017-04-20 Introduced in House IntroReferral Intro-H 9 Library of Congress 2017-04-20 Introduced in House IntroReferral 1000 9 Library of Congress S001187 Rep. Stivers, Steve [R-OH-15] Steve Stivers R OH 15 N R000577 Rep. Ryan, Tim [D-OH-13] TIM RYAN D OH 13 2017-04-20 True B001298 Rep. Bacon, Don [R-NE-2] Don Bacon R NE 2 2017-05-16 False Health Administrative law and regulatory procedures Department of Health and Human Services Drug safety, medical device, and laboratory regulation Europe European Union Food and Drug Administration (FDA) Prescription drugs Health 00 2017-04-20 Introduced in House 2017-04-24T13:57:56Z Speeding Access to Already Approved Pharmaceuticals Act of 2017

This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration to facilitate the development and expedite the review of a new drug, biological product, or medical device that has been approved in the European Union.

]]> Speeding Access to Already Approved Pharmaceuticals Act of 2017 Display Title Speeding Access to Already Approved Pharmaceuticals Act of 2017 Official Title as Introduced To require the Food and Drug Administration to expedite review of pharmaceuticals that are approved for marketing in the European Union. Introduced in House IH Short Titles as Introduced Speeding Access to Already Approved Pharmaceuticals Act of 2017 Introduced in House 2017-04-20T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-115hr2113ih/xml/BILLS-115hr2113ih.xml 2017-04-21 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.